I think the biggest deal for this company in the coming months that could jack up the PPS to at least 30 cents is to become fully SEC reporting. This is the most important missing piece that has been deterring many big players from investing in this company for long term. If they could also officially get the $10 million agreement signed by Benchmark around the same time, and announce the acquisition of a third pharmacy location, well, 50 cents could be well in the range then.
Market Data 
Markets 
AI
